Triprorelin for injection
QLG2051-01
Phase 1 small_molecule active
Quick answer
Triprorelin for injection for Prostate Cancer (CRPC) is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Prostate Cancer (CRPC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active